For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260513:nRSM0478Ea&default-theme=true
RNS Number : 0478E Schroder AsiaPacific Fund PLC 13 May 2026
13 May 2026
Schroder AsiaPacific Fund plc
Directorate Change
Schroder AsiaPacific Fund plc (the "Company") is pleased to announce the
appointment of Ian Cadby as an independent non-executive Director of the
Company, with effect from 13 May 2026. He will also be a member of the Audit
and Risk, Nomination and Management Engagement Committees.
Mr Cadby has over 35 years' asset management experience, including seven years
in Asia where he ran multi-asset portfolios. Formerly Chief Executive Officer
and Chief Investment Officer of Liberty Ermitage Ltd, he brings deep expertise
in board strategy & governance, derivative trading, and risk management.
He has over 10 years' experience on investment trust boards, including as
Chair and Senior Independent Director. Mr Cadby is a Fellow of the Chartered
Institute for Securities & Investment and a Chartered Director of the
Institute of Directors. He stepped down from the Board of Aberdeen Asian
Income Fund Ltd on 12 May 2026 and remains Senior Independent Director of CQS
New City High Yield Fund Ltd.
Nicky Richards, Chair of the Company, commented:
"We are pleased to appoint Ian Cadby to the Board. Ian offers a rare
combination of Asia multi-asset investment experience and extensive investment
trust board leadership, underpinned by strong risk and derivatives expertise.
His insight will be invaluable to our committee work and to the Company's
governance and oversight."
It is confirmed that there are no other details to be disclosed concerning Mr
Cadby under UK Listing Rule 6.4.8R.
Enquiries:
Natalia de Sousa
Schroder Investment Management Limited
Tel: 0207 658 6000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAGPUBGAUPQGQP
Copyright 2019 Regulatory News Service, all rights reserved